InsidersTradesSigma
Follow the 福安药业 stock price and the full directors' dealings record of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 福安药业 has recorded 2 public disclosures. Market capitalisation: €4.4bn. The latest transaction was filed on 31 January 2023 (Sale). Among the most active insiders: 程靖稀. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
福安药业 is a company specializing in the health and pharmaceutical sector. It is listed on the XSHE market.